Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia 14Leukemia, Myeloid, Acute 9Congenital Abnormalities 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 5Myeloproliferative Disorders 4Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Anemia, Refractory, with Excess of Blasts 4Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Precancerous Conditions 2Polycythemia Vera 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Prolymphocytic 2

Interventions

Lenalidomide 7Dexamethasone 5Calcium Dobesilate 4elotuzumab 2Denosumab 2siltuximab 1piperine 1ixazomib 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Urination 1Receptors, Interleukin-6 1Peripheral Blood Stem Cell Transplantation 1PVX-410 vaccine 1Nivolumab 1Melphalan 1Maintenance 1Interleukin 1 Receptor Antagonist Protein 1In Situ Hybridization, Fluorescence 1Immunotherapy, Active 1IPH-2101 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytogenetic Analysis 1Cyclophosphamide 1Curcumin 1Celecoxib 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Smoldering Multiple Myeloma × Cytogenetic Analysis × Clear all
NCT00112827 2025-06-06

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

City of Hope Medical Center

Phase 1/2 Completed
54 enrolled 13 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡